Thalys Medical Technology Group Corporation (SHA:603716)
15.95
-0.64 (-3.86%)
Nov 2, 2026, 2:24 PM CST
SHA:603716 Market Cap
SHA:603716 has a market cap or net worth of 3.54 billion as of October 30, 2026. It is the 14,061st most valuable company in the world and the 3,657th biggest in China. Its market cap has decreased by 31.37% in one year.
Market Cap
3.54B
Enterprise Value
3.62B
Revenue
709.31M
Global Rank
Country Rank
#3,657 China
PE Ratio
n/a
ChartMarket Cap Chart
Since October 31, 2016, SHA:603716's market cap has increased from 1.97B to 3.54B, an increase of 79.23%. That is a compound annual growth rate of 6.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 3.54B | -16.51% |
| Dec 31, 2025 | 4.24B | 213.84% |
| Dec 31, 2024 | 1.35B | -36.50% |
| Dec 29, 2023 | 2.13B | 0.51% |
| Dec 30, 2022 | 2.12B | -24.46% |
| Dec 31, 2021 | 2.80B | -14.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Strong Biotechnologies,Inc. | 7.29B |
| Amoy Diagnostics | 7.27B |
| Shanghai Runda Medical Technology | 5.54B |
| Maccura Biotechnology Co.Ltd | 5.43B |
| Cowealth Medical China | 4.19B |
| Shanghai Labway Clinical Laboratory | 4.04B |
| Medicalsystem Biotechnology | 3.65B |
| Guangdong Hybribio Biotech | 3.60B |